Cargando…
Association between glucocorticoids treatment and viral clearance delay in patients with COVID-19: a systematic review and meta-analysis
BACKGROUND: Evidence of glucocorticoids on viral clearance delay of COVID-19 patients is not clear. METHODS: In this systematic review and meta-analysis, we searched for studies on Medline, Embase, EBSCO, ScienceDirect, Web of Science, Cochrane Library, and ClinicalTrials.gov from 2019 to April 20,...
Autores principales: | Li, Jianbo, Liao, Xuelian, Zhou, Yue, Wang, Luping, Yang, Hang, Zhang, Wei, Zhang, Zhongwei, Kang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514812/ https://www.ncbi.nlm.nih.gov/pubmed/34649502 http://dx.doi.org/10.1186/s12879-021-06548-z |
Ejemplares similares
-
Glucocorticoid therapy does not delay viral clearance in COVID-19 patients
por: Ji, Jingjing, et al.
Publicado: (2020) -
Risk factors for the delayed viral clearance in COVID‐19 patients
por: Chen, Xiaoping, et al.
Publicado: (2021) -
Delayed Clearance of Viral RNA in Sputum for Severity COVID-19 Patients with Initial High Viral Load
por: Zhao, Hong, et al.
Publicado: (2022) -
Glucocorticoids: COVID-19 infection and delayed clearance of SARS-CoV-2 RNA: case report
Publicado: (2020) -
Immunosuppressants: Covid-19 pneumonia and delayed viral clearance: case report
Publicado: (2021)